Bazedoxifene coupled with conjugated estrogens improves menopausal symptoms in 3 phase III trials May 29, 2009
Post hoc subanalysis of phase III trials reveals no age-dependent effects of epoetin zeta in CKD May 28, 2009
Bristol-Myers Squibb claims glucocorticoid receptor modulators for the treatment of obesity May 28, 2009
Novel histamine H3 receptor inverse agonist developed by Roche for the treatment of obesity May 27, 2009
RSS